A Model-Informed Drug Development (MIDD) Approach for a Low Dose of Empagliflozin in Patients with Type 1 Diabetes.

Pharmaceutics · 2021 · PMC8066500 · PMID 33918261

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

There were no apparent correlations between continuous covariates with the exception of age and eGFR, and no overt trends in continuous covariates were observed except for a slight trend towards higher baseline HbA1c with increased IDB.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.